A 12-month, Phase 3, Open-label, Multi-center Study to Evaluate the Long-term Safety of PN400 (VIMOVO)
Clinical trial NCT00527904 · COMPLETED
Trial details
- NCT number
- NCT00527904
- Sponsor
- POZEN
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-01
- Primary completion
- 2009-03-01
- Enrollment
- 239
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.